H&Q Life Sciences Investors renews buyback of up to 12% of shares through July 10, 2014
The Board of Trustees of H&Q Life Sciences Investors authorized a renewal of the Fund's share repurchase program, as announced in a March 22, 2013 press release. The renewed program lets the Fund buy back up to 12% of its outstanding common shares in the open market through July 10, 2014, a one-year extension of the current program's July 10, 2013 end date. The Board says the program aims to narrow the discount between the share price and net asset value per share.
Key points
- Renewed program allows open-market purchases of up to 12% of outstanding common shares.
- Renewed program runs for one year, ending July 10, 2014; the current program ends July 10, 2013.
- Tekla Capital Management LLC, the Fund's investment adviser, will decide the amount and timing of repurchases.
- The filing states there is no assurance of purchases at any specific discount level, amount or date.
The filing
Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 25, 2013.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.